Resistant Cancer Cell Line Collection

Jindrich Cinatl
Dr Petra Joh-Forschungshaus
Frankfurter Stiftung für krebskranke Kinder
Frankfurt am Main, Germany

Wass-Michaelis Research Group
School of Biosciences
University of Kent
Kent, UK
Investigate Data for a single Drug: gemcitabine
Gemcitabine - Drug Information
Basic information about the drug is displayed below. This has been extracted from the Wikipedia entry for the drug - https://en.wikipedia.org/wiki/Gemcitabine
Drug Structure
Gemcitabine.svg
Gemcitabine-hydrochloride-from-xtal-3D-balls.png
Clinical data
Trade names Gemzar, others
AHFS/Drugs.com Monograph
Pregnancy
category
US: D (Evidence of risk)
Routes of
administration
Intravenous
ATC code L01BC05 (WHO)
Pharmacokinetic data
Protein binding < 10%
Biological half-life Short infusions: 32–94 minutes
Long infusions: 245–638 minutes
Identifiers
Synonyms 2', 2'-difluoro 2'deoxycytidine, dFdC
CAS Number 95058-81-4<
PubChem CID 60750
DrugBank DB00441
ChemSpider 54753
KEGG D02368
ChEBI CHEBI:175901
ChEMBL CHEMBL888
Gemcitabine Drug sensitivity Data
The table and barchart show all drug sensitivity data for gemcitabine

In the bar chart resistant sub-lines are shown in a lighter shade of the parental cell line